Idiopathic hypersomnia (IH) is a life-disrupting condition characterized by excessive daytime sleepiness (EDS) that makes waking up a daily struggle, limits productivity, and erodes overall quality of life. For many patients with IH, the journey to diagnosis is long and …

The emergence of HER2-low and ultralow classifications in mBC (mBC) is reshaping treatment options, offering new hope for patients who were once considered ineligible for targeted therapy. Yet many clinicians face uncertainty about how to appropriately define these new phenotypes …

Fibrosis remains one of the greatest unmet needs in inflammatory bowel disease (IBD), contributing to irreversible structural bowel damage, complications, and long-term morbidity despite advances in anti-inflammatory therapies. Many gastroenterologists and multidisciplinary gastrointestinal (GI) care teams lack confidence in recognizing …

For people living with ulcerative colitis (UC), cycles of remission and relapse can disrupt daily life and complicate long-term management. Sphingosine-1-phosphate receptor modulators (S1Prms) are a new class of targeted oral therapies with the potential to reduce colonic inflammation and …

In this CME Outfitters Engage the Experts recorded session, the community-based expert faculty from the Project ECHO® series will provide a comprehensive summary of key insights from the five-session CIDP Masterclass: Early Diagnosis, Emerging Options, Better Outcomes – A Project …

In this opening conversation, Lee M. Kaplan, MD, PhD, joins series chair Robert F. Kushner, MD, to make a deceptively simple case: because no single mechanism drives obesity in every patient, no single mechanism will treat it in every patient. …

Although treatment advances in inflammatory bowel disease (IBD) have improved symptom control, many patients continue to experience progressive structural bowel damage and systemic complications that are not adequately addressed in routine care. Gastroenterologists and multidisciplinary gastrointestinal (GI) care teams often …

Endometriosis is a chronic inflammatory condition that remains underrecognized and undertreated, leaving many individuals of reproductive age with daily pain and disruption. Patients often face preference‑sensitive decisions about pain management, contraception, and fertility without clear guidance, frequently after years‑long diagnostic …

Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …

Lennox-Gastaut syndrome (LGS) affects every aspect of patients’ and caregivers’ lives, often far beyond seizures alone. Families face a fragmented system, where pediatric and adult care are poorly aligned, social services are hard to navigate, and long-term planning is unsupported. …

Complicated urinary tract infections (cUTIs) represent an important and growing challenge in clinical practice, affecting individual patients’ health and quality of life while exerting a substantial burden on the healthcare system. Despite being common, these infections are underrecognized. The July …

Comprehensive patient assessment and accurate risk stratification are cornerstones of effective inpatient management of SARS-CoV-2. However, the absence of a clear consensus on how to categorize patients by risk—and the limited availability of validated, reliable scoring systems—continues to challenge clinical …

Retinal disease includes a wide array of conditions affecting the retina that, if not detected and treated early, can significantly impair quality of life, independence, and mobility while increasing the risk of accidental injury. These conditions also impose a substantial …

Despite major advances in inflammatory bowel disease (IBD) management, real-world data show that many patients continue to experience suboptimal outcomes due to misaligned treatment goals, therapeutic inertia, and limited integration of novel therapies, particularly IL-23 inhibitors—into individualized care plans. While …

As HIV prevention strategies continue to evolve, healthcare professionals across the globe face persistent knowledge gaps in evaluating and integrating the latest pre-exposure prophylaxis (PrEP) options, including long-acting injectable (LAI) agents. Many clinicians worldwide remain unfamiliar with the mechanisms of …

Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) represents a major advancement in HIV prevention, offering new opportunities to support adherence and reduce transmission, yet its optimal use remains underrealized across global healthcare settings. Many HIV/infectious disease specialists, primary care clinicians, and …

Multiple sclerosis (MS) is a chronic, immune-mediated disease in which early, individualized disease-modifying therapy (DMT) can reduce disease activity, delay disability progression, and preserve quality of life. As therapeutic options expand—particularly multiple anti-CD20 therapies with different dosing schedules, administration routes, …

Despite significant strides in HIV prevention, global incidence rates remain high, especially among underserved populations, due in part to persistent barriers in routine screening and access to pre-exposure prophylaxis (PrEP). Many healthcare professionals across the globe, including HIV and infectious …

In this CME Outfitters recorded webcast, expert faculty will review current ASCVD risk assessment guidelines, highlight the importance of achieving recommended LDL-C targets in intermediate- and high-risk patients, and discuss practical strategies to optimize therapeutic decision-making in clinical practice.

Learn …

Across diverse global settings, patient engagement and sustained adherence remain major challenges in HIV prevention, particularly with pre-exposure prophylaxis (PrEP). Barriers such as insufficient provider training in communication strategies, in addition to broader issues such as stigma, limited health literacy, …

In this Creative Educational Concepts recorded webcast, expert faculty will delineate class-wide and agent-specific characteristics of ADCs, including mechanism of action, relevant biomarkers, efficacy, toxicity profiles, and considerations for sequencing and integration of IO therapies in biomarker-selected mNSCLC. Faculty will …

In this CE Concepts recorded webcast, expert faculty will review recent developments in the management of advanced or recurrent EC, with a focus on applying emerging clinical evidence, integrating biomarker-driven therapies, and addressing treatment-related toxicities. This program will further explore …

Supported by an educational grant from Bristol Myers Squibb.

 …